The World Health Organization (WHO) has long been regarded as the backbone of global health initiatives, coordinating responses to outbreaks and setting international health standards. Yet, behind its noble mission lies a critical, often overlooked question: who pays for the WHO, and what does that mean for its ability to prioritise global health needs?
The reality is more complicated—and troubling—than it seems. The organisation’s funding structure is heavily reliant on a mix of assessed contributions (mandatory membership fees) and voluntary donations, the latter often dictating its agenda. This dependence raises significant concerns about the WHO’s autonomy and its effectiveness as a global health leader.
Who Are the Biggest Donors to the WHO?
The WHO’s $6.5 billion budget for 2024-2025 paints a stark picture of its financial dependence. A substantial 70% of its funding comes from voluntary contributions, where donors specify how their money should be spent. This dynamic allows wealthier countries, private organisations, and corporations to wield disproportionate influence over the WHO’s agenda.
Here’s a list of the WHO’s largest donors for the current budget cycle:
- United States: $958 million (15% of total budget)
- Bill & Melinda Gates Foundation: $689 million
- Gavi, The Vaccine Alliance: $500 million
- European Commission: $412 million
- Germany: $324 million
- World Bank: $268 million
- United Kingdom: $215 million
- Canada: $141 million
- European Investment Bank: $119 million
While the U.S. remains the WHO’s largest donor, it’s worth noting the significant influence of private entities like the Gates Foundation and Gavi. This raises critical questions about the balance of power within the organisation and the potential for conflicts of interest.
Voluntary Contributions: A Double-Edged Sword
The reliance on voluntary contributions creates a glaring vulnerability for the WHO. Unlike assessed contributions, which are relatively stable and untied, voluntary donations come with strings attached. Donors often earmark funds for specific programmes that align with their interests, leaving the WHO with limited flexibility to address pressing health crises that may not capture global attention.
For example, while diseases like polio and malaria receive significant funding due to donor priorities, other urgent health issues—such as neglected tropical diseases or mental health—often remain underfunded. This imbalance undermines the WHO’s ability to act as an impartial global health authority, instead forcing it to cater to the whims of its wealthiest contributors.
A Tenuous Push for Reform
Recognising these challenges, WHO member states agreed in 2022 to reform the organisation’s financing model. The goal? To increase the share of assessed contributions to 50% of its budget by 2030. However, this ambitious target faces significant hurdles, not least the reluctance of member states to pay higher mandatory fees.
The ongoing reliance on voluntary contributions makes it doubtful that the WHO can ever achieve true financial independence. And without that independence, the organisation’s ability to set its own public health priorities remains compromised.
The U.S. Withdrawal: A Blow to Global Health?
Former President Donald Trump’s decision to exit the WHO during his term was a stark reminder of the political fragility of global health funding. By cutting ties with the organisation, the U.S. temporarily halted its contributions, creating a funding shortfall that threatened to derail critical health initiatives.
Although President Joe Biden reversed this decision and reinstated U.S. funding, the episode highlighted the risks of overreliance on a single donor. The WHO’s financial stability—and by extension, global health security—should not hinge on the political whims of any one country.
Private Donors: Help or Hindrance?
The growing influence of private donors like the Gates Foundation also merits scrutiny. While their contributions have undoubtedly advanced critical health initiatives, they also raise concerns about accountability and the potential for conflicts of interest.
Private donors often prioritise high-profile issues, such as vaccine development, that align with their philanthropic goals. But what about less glamorous health challenges, like healthcare infrastructure in low-income countries? These areas often struggle to attract funding, leaving the WHO with gaps in its ability to address global health inequities.
Moreover, the involvement of private entities raises ethical questions about the transparency of decision-making within the WHO. Are the organisation’s priorities truly driven by global health needs, or are they skewed by the interests of its most generous donors?
The Power Imbalance in Global Health
The WHO’s funding model underscores a broader issue: the power imbalance in global health governance. Wealthier nations and private donors wield disproportionate influence over the organisation’s agenda, while poorer countries—those most in need of the WHO’s support—often have little say in how resources are allocated.
This imbalance is particularly evident in vaccine distribution. While the WHO played a crucial role in coordinating the global response to COVID-19, disparities in vaccine access highlighted the limitations of its influence. Wealthier nations secured the majority of vaccine supplies, leaving lower-income countries to rely on programmes like COVAX—an initiative heavily dependent on voluntary contributions.
Is the WHO Still Fit for Purpose?
As the world’s leading health authority, the WHO is tasked with addressing some of humanity’s most pressing challenges. Yet its financial dependence on a handful of powerful donors raises doubts about its ability to fulfil this mandate.
Can the WHO truly act as an impartial global health leader when its funding is so heavily influenced by external interests? Can it prioritise the needs of the world’s most vulnerable populations when its resources are dictated by the agendas of wealthier nations and private entities?
The answers to these questions are far from reassuring. Until the WHO achieves greater financial independence, its ability to act as a truly representative global health authority will remain compromised.
Conclusion: A System in Need of Overhaul
The World Health Organization’s funding model is emblematic of a system that prioritises wealth over equity, influence over impartiality. While its work has undoubtedly saved countless lives, the organisation’s financial vulnerabilities threaten to undermine its mission.
For the WHO to truly fulfil its mandate, it needs more than just reforms—it needs a complete overhaul of its funding structure. Member states must step up to provide stable, untied funding that allows the organisation to set its own priorities based on global health needs, not donor interests.
Until then, the WHO will remain a global health giant with feet of clay—powerful in theory but perpetually hamstrung by the very system it depends on. The question is: will the world act before it’s too late?